Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	79.38	57.26	80.93	178.27	305.74
Cash & Short-Term Investments	79.38	57.26	80.93	178.27	305.74
Cash Growth	38.63%	-29.24%	-54.60%	-41.69%	31.02%
Accounts Receivable	29.78	10.23	15.22	28.21	23.11
Other Receivables	0.16	0.17	0.17	0.14	0.68
Total Trade Receivables	29.94	10.4	15.39	28.35	23.79
Inventory	9.62	14.43	10.21	14.16	9.86
Other Current Assets	4.9	8.28	10.5	9.66	7.07
Total Current Assets	123.84	90.37	117.02	230.43	346.46
Net Property, Plant & Equipment	14.82	17.12	23.5	33.01	34.07
Other Intangible Assets	27.61	31.86	20.29	27.2	12.55
Long-Term Investments	17.66	2.59	-	-	-
Other Long-Term Assets	1.62	2.28	6.72	3.66	3.42
Total Assets	185.55	144.22	167.53	294.3	396.5
Accounts Payable	47.13	65.5	73.56	97.45	90.66
Short-Term Debt	-	-	-	2.95	0.81
Current Portion of Long-Term Debt	-	-	3.93	2.05	-
Current Portion of Leases	2.13	2.62	2.52	2.45	2.1
Unearned Revenue	-	-	-	-	2.61
Other Current Liabilities	0.49	3.28	4.89	22.82	4.86
Total Current Liabilities	49.74	71.4	84.91	127.72	101.04
Long-Term Debt	52.42	57.96	60.86	91.73	42.94
Long-Term Leases	12.67	14.75	18.28	21.57	20.99
Other Long-Term Liabilities	8.53	1.76	1.89	3.26	5.66
Total Long-Term Liabilities	73.62	74.47	81.03	116.56	69.58
Total Liabilities	123.37	145.87	165.94	244.28	170.63
Preferred Stock	0	0	0	0	0
Common Stock	0.03	0.03	0.02	0.01	0.1
Additional Paid-in Capital	783.89	763.57	717.4	675.94	656.03
Retained Earnings	-734.05	-740.87	-694.87	-634.23	-547.46
Total Common Shareholders' Equity	49.87	22.74	22.54	41.72	108.67
Minority Interest	12.31	-24.38	-20.96	8.3	117.2
Shareholders' Equity	62.18	-1.64	1.59	50.03	225.88
Total Liabilities & Equity	185.55	144.22	167.53	294.3	396.5
Total Debt	67.22	75.34	85.59	120.75	66.84
Net Cash (Debt)	12.17	-18.07	-4.67	57.52	238.9
Net Cash Growth	-	-	-	-75.92%	52.23%
Net Cash Per Share	0.44	-0.87	-0.57	9.71	43.86
Book Value	49.87	22.74	22.54	41.72	108.67
Book Value Per Share	1.79	1.09	2.78	7.04	19.95
Tangible Book Value	22.27	-9.13	2.26	14.52	96.12
Tangible Book Value Per Share	0.80	-0.44	0.28	2.45	17.65

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q